[HTML][HTML] Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
Understanding mucosal antibody responses from SARS-CoV-2 infection and/or vaccination
is crucial to develop strategies for longer term immunity, especially against emerging viral …
is crucial to develop strategies for longer term immunity, especially against emerging viral …
[HTML][HTML] IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
LO Fernandes-Siqueira, BG Sousa, CE Cleto… - Journal of Clinical …, 2022 - Elsevier
Background Vaccination against COVID-19 was implemented very quickly, but the
emergence of new variants that can evade the previous acquired immunological protection …
emergence of new variants that can evade the previous acquired immunological protection …
Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV
SG De-Simone, P Napoleão-Pêgo, GC Lechuga… - Vaccines, 2023 - mdpi.com
Background: The newly introduced COVID-19 vaccines have reduced disease severity and
hospitalizations. However, they do not significantly prevent infection or transmission. In the …
hospitalizations. However, they do not significantly prevent infection or transmission. In the …
[HTML][HTML] Potential of high‐titre IgA convalescent plasma to improve survival and symptoms in COVID‐19 patients
A Kuś, S Wieczorek, J Dybko… - European Journal of …, 2023 - ncbi.nlm.nih.gov
Potential of high‐titre IgA convalescent plasma to improve survival and symptoms in COVID‐19
patients - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
patients - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
Influenza vaccination as a prognostic factor of humoral IgA responses to SARS-CoV-2 infection
B Poniedziałek, D Sikora, E Hallmann… - … European Journal of …, 2024 - termedia.pl
There is evidence that influenza vaccination may provide additional benefits by inducing
training of innate immunity and increasing humoral responses to heterologous challenges …
training of innate immunity and increasing humoral responses to heterologous challenges …
Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough
Understanding mucosal antibody responses from SARS-CoV-2 infection and/or vaccination
is crucial to develop strategies for longer term immunity, especially against emerging viral …
is crucial to develop strategies for longer term immunity, especially against emerging viral …
The beneficial role of Candida intermedia and Saccharomyces boulardii yeasts on the immune response of mice vaccinated with a SARS-CoV-2 experimental …
REA Piraine, NL Conrad, VS Gonçalves, JV Ramos… - bioRxiv, 2021 - biorxiv.org
Non-Saccharomyces yeasts emerge as possible new probiotics with a beneficial effect
equal to or greater than the reference probiotic yeast, Saccharomyces boulardii. In this work …
equal to or greater than the reference probiotic yeast, Saccharomyces boulardii. In this work …
IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
LOF Siqueira, BG Sousa, CE Cleto, LS Wermelinger… - 2022 - arca.fiocruz.br
Background: Vaccination against COVID-19 was implemented very quickly, but the
emergence of new variants that can evade the previous acquired immunological protection …
emergence of new variants that can evade the previous acquired immunological protection …
[引用][C] Pathogen reduction technologies need to evaluate Fc-mediated antibody functions.
D Focosi, A Casadevall - Transfusion, 2022 - europepmc.org
Pathogen reduction technologies need to evaluate Fc-mediated antibody functions. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …